Correction: Secondary outcomes and qualitative findings of an open-label feasibility trial of lisdexamfetamine dimesylate for adults with bulimia nervosa

• Laura Dixon,
• Sara Bartel,
• Victoria Brown,
• Sarrah I. Ali,
• Susan Gamberg,
• Andrea Murphy,
• Katherine L. Brewer,
• Susan L. McElroy,
• Allan Kaplan,
• Abraham Nunes,
• Aaron R. Keshen

Affiliations

Laura Dixon

Eating Disorder Program, Nova Scotia Health Authority

Sara Bartel

Eating Disorder Program, Nova Scotia Health Authority

Victoria Brown

Eating Disorder Program, Nova Scotia Health Authority

Sarrah I. Ali

Eating Disorder Program, Nova Scotia Health Authority

Susan Gamberg

Eating Disorder Program, Nova Scotia Health Authority

Andrea Murphy

Department of Psychiatry, Dalhousie University

Katherine L. Brewer

College of Doctoral Studies, University of Phoenix

Susan L. McElroy

Lindner Center of HOPE

Allan Kaplan

Department of Psychiatry, Centre for Addiction and Mental Health, Institute of Medical Science, University of Toronto

Abraham Nunes

Department of Psychiatry, Dalhousie University

Aaron R. Keshen

Eating Disorder Program, Nova Scotia Health Authority